| Review Article | ||
J Cancer Res Rev. 2026; 3(1): 1-19 | ||
| How to Cite this Article |
| Pubmed Style Oladosu MA, Abah MA, Yohanna NR, Asogwa N, Ameh S, Asogwa K, Awojulu T, Oteng J, Adejumo JO, Balogun OA, Akuoko MO. A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. J Cancer Res Rev. 2026; 3(1): 1-19. doi:10.5455/JCRR.2026.v3.i1.1 Web Style Oladosu MA, Abah MA, Yohanna NR, Asogwa N, Ameh S, Asogwa K, Awojulu T, Oteng J, Adejumo JO, Balogun OA, Akuoko MO. A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. https://www.jcrronline.org//?mno=259787 [Access: June 26, 2026]. doi:10.5455/JCRR.2026.v3.i1.1 AMA (American Medical Association) Style Oladosu MA, Abah MA, Yohanna NR, Asogwa N, Ameh S, Asogwa K, Awojulu T, Oteng J, Adejumo JO, Balogun OA, Akuoko MO. A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. J Cancer Res Rev. 2026; 3(1): 1-19. doi:10.5455/JCRR.2026.v3.i1.1 Vancouver/ICMJE Style Oladosu MA, Abah MA, Yohanna NR, Asogwa N, Ameh S, Asogwa K, Awojulu T, Oteng J, Adejumo JO, Balogun OA, Akuoko MO. A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. J Cancer Res Rev. (2026), [cited June 26, 2026]; 3(1): 1-19. doi:10.5455/JCRR.2026.v3.i1.1 Harvard Style Oladosu, M. A., Abah, . M. A., Yohanna, . N. R., Asogwa, . N., Ameh, . S., Asogwa, . K., Awojulu, . T., Oteng, . J., Adejumo, . J. O., Balogun, . O. A. & Akuoko, . M. O. (2026) A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. J Cancer Res Rev, 3 (1), 1-19. doi:10.5455/JCRR.2026.v3.i1.1 Turabian Style Oladosu, Micheal Abimbola, Moses Adondua Abah, Nathan Rimamsanati Yohanna, Nkechi Asogwa, Sunday Ameh, Kelechi Asogwa, Taiwo Awojulu, Joseph Oteng, Jesufikunayomi Omobola Adejumo, Oladapo Abiola Balogun, and Manasseh Opoku Akuoko. 2026. A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. Journal of Cancer Research and Reviews, 3 (1), 1-19. doi:10.5455/JCRR.2026.v3.i1.1 Chicago Style Oladosu, Micheal Abimbola, Moses Adondua Abah, Nathan Rimamsanati Yohanna, Nkechi Asogwa, Sunday Ameh, Kelechi Asogwa, Taiwo Awojulu, Joseph Oteng, Jesufikunayomi Omobola Adejumo, Oladapo Abiola Balogun, and Manasseh Opoku Akuoko. "A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine." Journal of Cancer Research and Reviews 3 (2026), 1-19. doi:10.5455/JCRR.2026.v3.i1.1 MLA (The Modern Language Association) Style Oladosu, Micheal Abimbola, Moses Adondua Abah, Nathan Rimamsanati Yohanna, Nkechi Asogwa, Sunday Ameh, Kelechi Asogwa, Taiwo Awojulu, Joseph Oteng, Jesufikunayomi Omobola Adejumo, Oladapo Abiola Balogun, and Manasseh Opoku Akuoko. "A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine." Journal of Cancer Research and Reviews 3.1 (2026), 1-19. Print. doi:10.5455/JCRR.2026.v3.i1.1 APA (American Psychological Association) Style Oladosu, M. A., Abah, . M. A., Yohanna, . N. R., Asogwa, . N., Ameh, . S., Asogwa, . K., Awojulu, . T., Oteng, . J., Adejumo, . J. O., Balogun, . O. A. & Akuoko, . M. O. (2026) A comprehensive review of targeted therapies for triple-negative breast cancer: From molecular subtypes to precision medicine. Journal of Cancer Research and Reviews, 3 (1), 1-19. doi:10.5455/JCRR.2026.v3.i1.1 |
